Butyric Acid

Butyric Acid

SCHEMBL845266

CCCC(=O)O.CCOC(C)=O

nearest known ligand 0.67

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.67
HSD17B10 Q99714 2/20 0.67
LMNA P02545 2/20 0.67
FFAR3 O14843 1/20 0.62
HDAC3 O15379 1/20 0.62
HDAC1 Q13547 1/20 0.62
HDAC2 Q92769 1/20 0.62
HDAC8 Q9BY41 1/20 0.62
TSHR P16473 5/20 0.43
AKR1B1 P15121 1/20 0.42
GPR84 Q9NQS5 7/20 0.41
PPARG P37231 7/20 0.41
PPARD Q03181 7/20 0.41
PPARA Q07869 7/20 0.41
HDAC11 Q96DB2 5/20 0.41
PTPN1 P18031 3/20 0.41
TLR2 O60603 2/20 0.41
TDP1 Q9NUW8 2/20 0.41
FABP4 P15090 2/20 0.41
SLC22A6 Q4U2R8 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Butyric Acid SCHEMBL31546267 1.00 ALDH1A1 (0.67) ALDH1A1HSD17B10LMNAFFAR3HDAC3
Butyric Acid SCHEMBL27885948 0.98 ALDH1A1 (0.64) ALDH1A1HSD17B10LMNAFFAR3HDAC3
Butyric Acid SCHEMBL3939998 0.94 ALDH1A1 (0.58) ALDH1A1HSD17B10LMNAFFAR3HDAC3
Butyric Acid SCHEMBL20720532 0.92 ALDH1A1 (0.56) ALDH1A1HSD17B10LMNAFFAR3HDAC3
Valeric Acid SCHEMBL454061 0.86 ALDH1A1 (0.61) ALDH1A1HSD17B10LMNAFFAR3HDAC3
Ethyl Acetate SCHEMBL19278915 0.86 ALDH1A1 (0.61) ALDH1A1HSD17B10LMNAFFAR3HDAC3
Adipic Acid SCHEMBL11807980 0.86 ALDH1A1 (0.67) ALDH1A1HSD17B10LMNATSHRAKR1B1
Butyric Acid SCHEMBL19065006 0.86 FFAR3 (0.62) ALDH1A1HSD17B10LMNAFFAR3HDAC3
Glutarate SCHEMBL28199588 0.86 ALDH1A1 (0.67) ALDH1A1HSD17B10LMNATSHRAKR1B1
Butyric Acid SCHEMBL31534016 0.85 PAM (0.56) ALDH1A1HSD17B10LMNATSHRAKR1B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 701 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4617334-A1 INKJET INK General Co., Ltd. (JP) 2025-09-17 EP claimed
CN-120037403-A Preparation method of ROS response drug-loaded double-targeting nano delivery system for treating diabetic nephropathy 浙江大学医学院附属邵逸夫医院 2025-05-27 CN claimed
CN-119431333-A Method for extracting flavonoid compounds from epimedium herb of arrow leaf and application 河南中医药大学 2025-02-14 CN claimed
CN-113727962-B Methods and compounds for preparing orexin-2 receptor antagonists, and reduced impurity lebol Lei Sheng 卫材R&D管理有限公司 2024-10-22 CN claimed
CN-117915920-A Use of terpenoids in the treatment or prevention of fibrotic diseases 吉亚生技控股股份有限公司 2024-04-19 CN claimed
CN-116744953-A Use of terpenoids in the treatment or prevention of fibrotic diseases 吉亚生技控股股份有限公司 2023-09-12 CN claimed
WO-2023136458-A1 COATING FILTER AND HOOD TO WHICH SAME IS APPLIED 삼성전자주식회사 2023-07-20 WO claimed
CN-115917823-A Composition for gel polymer electrolyte and lithium secondary battery including gel polymer electrolyte formed from the same 株式会社LG新能源 2023-04-04 CN claimed
CN-115598276-A Method for judging quality grade of Maotai-flavor liquor based on content and proportion of volatile compounds 江南大学(CN) 2023-01-13 CN claimed
WO-2022186423-A1 METHOD FOR PREPARING MAX PRECURSOR AND MXENE NANOINK 전북대학교산학협력단 2022-09-09 WO claimed
WO-2022097813-A1 METHOD FOR PREPARING ESTER COMPOUND BASED ON ECO-FRIENDLY AND HIGH-EFFICIENCY ESTERIFICATION REACTION USING SALT ION-EXCHANGE METHOD, AND COMPOUND THEREOF 주식회사 우드워드바이오 2022-05-12 WO claimed
WO-2022092913-A1 CRYSTALLINE FORM III OF MELANOCORTIN RECEPTOR AGONIST COMPOUND AND METHOD FOR PREPARING SAME 주식회사 엘지화학 2022-05-05 WO claimed
WO-2022092910-A1 CRYSTAL TYPE II OF MALANOCORTIN RECEPTOR AGONIST COMPOUND AND METHOD FOR PREPARING SAME 주식회사 엘지화학 2022-05-05 WO claimed
WO-2022092914-A1 CRYSTAL FORM IV OF MELANOCORTIN RECEPTOR AGONIST COMPOUND, AND PREPARATION METHOD THEREFOR 주식회사 엘지화학 2022-05-05 WO claimed
WO-2022092909-A1 CRYSTALLINE FORM I OF MELANOCORTIN RECEPTOR AGONIST COMPOUND, AND METHOD FOR PREPARING SAME 주식회사 엘지화학 2022-05-05 WO claimed
WO-2022065942-A1 COMPOSITION FOR COATING MEDICAL DEVICE 가톨릭대학교 산학협력단 2022-03-31 WO claimed
CN-107875458-A A kind of degradable intrauterine device and preparation method thereof 杭州市妇产科医院 2018-04-06 CN claimed
US-20060078832-A1 Compositions for multi-color, light activated imaging HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. 2006-04-13 US claimed
WO-2005026839-A2 PHTHALOCYANINE PRECURSORS IN INFRARED SENSITIVE COMPOSITIONS HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. (US) 2005-03-24 WO claimed
US-20050053864-A1 Phthalocyanine precursors in infrared sensitive compositions HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. 2005-03-10 US claimed